ISBN-10:
1617370916
ISBN-13:
9781617370915
Pub. Date:
12/08/2010
Publisher:
Springer-Verlag New York, LLC
Platinum-Based Drugs in Cancer Therapy / Edition 1

Platinum-Based Drugs in Cancer Therapy / Edition 1

Current price is , Original price is $249.99. You

Temporarily Out of Stock Online

Please check back later for updated availability.

Product Details

ISBN-13: 9781617370915
Publisher: Springer-Verlag New York, LLC
Publication date: 12/08/2010
Series: Cancer Drug Discovery and Development
Edition description: Softcover reprint of hardcover 1st ed. 2000
Pages: 341
Product dimensions: 5.98(w) x 9.02(h) x 0.36(d)

Table of Contents

Part I: Platinum Chemistry. The Chemistry of Cisplatin in Aqueous Solution, Susan J. Berners-Price and Trevor G. Appleton. Chemistry and Structural Biology of 1,2-Interstrand Adducts of Cisplatin, Viktor Brabec. Transplatin-Modified Oligonucleotides as Potential Antitumor Drugs, Marc Leng, Annie Schwartz, and Marie-Josephe Giraud-Panis. Part II: Platinum Biochemistry. Cisplatin Accumulation, Paul A. Andrews. Cisplatin Resistance in Ovarian Cancer: Mismatch Repair and Engagement of Apoptosis, Robert Brown. DNA Adduct Tolerance and Bypass, Stephen G. Chaney and Alexandra Vaisman. How Does Cisplatin Kill Cells? Daniel Fink and Stephen B. Howell. Part III: Clinical Antitumor Activity and Toxicology of Platinum Drugs. Clinical Experience with Cisplatin and Carboplatin, M. S. Highley and A. H. Calvert. Clinical Experience: Platinum and Taxanes, Michelle Vaughan, Francisco Sapunar, and Martin Gore. Clinical Experience: DACH-Based Platinum Drugs, Peter J. O'Dwyer, James P. Stevenson, and Steven W. Johnson. Clinical Toxicology of Platinum-Based Cancer Chemotherapeutic Agents, Mark J. McKeage. Toxicology and Regulatory Aspects of Platinum Drugs, Diana L. Clark, Paul A. Andrews, D. D. Smith, Joseph J. DeGeorge, Robert L. Justice, and Julie G. Beitz. Part IV: New Platinum Drugs of the Future. New Platinum Drugs: The Pathway to Oral Therapy, Lloyd R. Kelland. Polynuclear Charged Platinum Compounds as a New Class of Anticancer Agents: Toward a New Paradigm, Nicholas Farrell. Index.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews